Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Hisse Senetlerindeki Sıralama #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Hisse Fiyatı
$59.98
Son senkronizasyon: 2024-12-13
Piyasa Değeri
$1.22B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

Longboard Pharmaceuticals, Inc. (LBPH) için kazanç
Sep 2024 itibarıyla kazanç TTM: $-76.34M
Longboard Pharmaceuticals, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı $-76.34M'dir. 2022 yılında şirket $-43.95M kazanç elde etti, bu 2021 yılındaki $-27.80M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Longboard Pharmaceuticals, Inc. için kazanç geçmişi 2020 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-76.34M 40.28%
2023 $-54.42M 23.84%
2022 $-43.95M 58.09%
2021 $-27.80M 93.03%
2020 $-14.40M 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$5.27B -7,009.38%
US
$1.95B -2,655.08%
NL
$-4.02B 5,160.66%
AU
$-3.09B 3,943.54%
US
- -
CH